Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000902664-24-006543
Filing Date
2024-11-14
Accepted
2024-11-14 10:11:45
Documents
1

Document Format Files

Seq Description Document Type Size
1 ONKURE THERAPEUTICS, INC. p24-3243sc13g.htm SC 13G 47149
  Complete submission text file 0000902664-24-006543.txt   49023
Mailing Address 277 PARK AVE 23RD FLOOR NEW YORK NY 10172
Business Address 277 PARK AVE 23RD FLOOR NEW YORK NY 10172 2122872500
HIGHBRIDGE CAPITAL MANAGEMENT LLC (Filed by) CIK: 0000919185 (see all company filings)

EIN.: 134131516 | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 6707 WINCHESTER CIRCLE, SUITE 400 BOULDER CO 80301
Business Address 6707 WINCHESTER CIRCLE, SUITE 400 BOULDER CO 80301 (720) 307-2892
OnKure Therapeutics, Inc. (Subject) CIK: 0001637715 (see all company filings)

EIN.: 472309515 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-92480 | Film No.: 241458128
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)